• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas.

作者信息

Buø L, Lyberg T, Jørgensen L, Johansen H T, Aasen A O

机构信息

Institute for Surgical Research, Rikshospitalet, Oslo, Norway.

出版信息

APMIS. 1993 Mar;101(3):235-41. doi: 10.1111/j.1699-0463.1993.tb00106.x.

DOI:10.1111/j.1699-0463.1993.tb00106.x
PMID:8507461
Abstract

Both the coagulation and fibrinolytic cascades generate proteolytic enzymes which appear to be essential for tumor invasion. In the present investigation adenocarcinomas and normal colon from 14 patients with colorectal cancer were studied by immunohistochemistry. The most striking observation was an enrichment of plasminogen activator inhibitor in the tumor tissue, whereas no such immunoreactivity was detected in the biopsies of normal colon. The tumor-host interface was characterized by a massive accumulation of inflammatory cells, macrophages and T lymphocytes. In this area fibrin(ogen) immunoreactivity as a sign of local activation of the coagulation cascade was also seen. The transition zone between the tumor and normal tissue was furthermore characterized by a marked enrichment of urokinase plasminogen activator immunoreactivity. The study strongly indicates that proteases and inhibitors of the fibrinolytic system may be of great importance in tumor invasion.

摘要

相似文献

1
Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas.
APMIS. 1993 Mar;101(3):235-41. doi: 10.1111/j.1699-0463.1993.tb00106.x.
2
Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis.人结直肠肿瘤中纤溶酶原激活剂及其抑制剂的失衡。尿激酶在结直肠癌发生中的意义。
Gastroenterology. 1991 Dec;101(6):1522-8. doi: 10.1016/0016-5085(91)90387-z.
3
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.纤溶酶原激活剂及其抑制剂对杜克B期和C期结直肠癌患者生存预后的影响
Br J Cancer. 1997;75(12):1793-801. doi: 10.1038/bjc.1997.306.
4
Immunohistochemical localization of coagulation, fibrinolytic and antifibrinolytic markers in adenocarcinoma of the lung.
APMIS. 1991 Nov;99(11):981-8. doi: 10.1111/j.1699-0463.1991.tb01288.x.
5
Prognostic value of plasminogen activators and their inhibitors in colorectal cancer.纤溶酶原激活剂及其抑制剂在结直肠癌中的预后价值。
Eur J Cancer. 1995 Jul-Aug;31A(7-8):1105-9. doi: 10.1016/0959-8049(95)00170-n.
6
Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness.尿激酶型纤溶酶原激活剂及其受体在结直肠癌肿瘤-宿主界面的抗原水平与肿瘤侵袭性相关。
Hum Pathol. 1995 Oct;26(10):1133-8. doi: 10.1016/0046-8177(95)90276-7.
7
Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.纤溶酶原激活剂与人类结肠癌的发展:正常黏膜、腺瘤性息肉及腺癌中的活性水平
Cancer Res. 1987 Sep 1;47(17):4654-7.
8
Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells.人结直肠癌组织中的纤溶酶原激活剂和纤溶酶原激活剂抑制剂并非由肿瘤细胞表达。
Eur J Cancer. 1993;29A(8):1184-9. doi: 10.1016/s0959-8049(05)80312-0.
9
Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer.卵巢癌患者血液和肿瘤液中的纤溶酶原激活剂及纤溶酶原激活剂抑制剂
Eur J Cancer. 1994;30A(9):1302-9. doi: 10.1016/0959-8049(94)90178-3.
10
Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces.炎症性肠病患者的纤维蛋白溶解功能紊乱。一项关于血浆、结肠黏膜和粪便的研究。
Gut. 1989 Feb;30(2):188-94. doi: 10.1136/gut.30.2.188.

引用本文的文献

1
The plasminogen activator inhibitor system in colon cancer cell lines is influenced by the CO2 pneumoperitoneum.CO2 气腹对结肠癌细胞系纤溶酶原激活物抑制剂系统的影响
Int J Colorectal Dis. 2011 Jan;26(1):37-43. doi: 10.1007/s00384-010-1062-y. Epub 2010 Oct 8.
2
Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization.通过免疫组织化学和原位杂交技术在结肠腺癌癌细胞中证明尿激酶的表达。
Am J Pathol. 1999 Oct;155(4):1115-20. doi: 10.1016/S0002-9440(10)65214-5.
3
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.
非小细胞肺癌中的纤溶酶级联反应与基质金属蛋白酶
Thorax. 1999 Feb;54(2):169-79. doi: 10.1136/thx.54.2.169.
4
Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover.尿激酶与肠黏膜:上皮细胞更新作用的证据
Gut. 1998 Nov;43(5):656-63. doi: 10.1136/gut.43.5.656.
5
Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.正常结肠上皮细胞在体外分泌尿激酶和纤溶酶原激活物抑制剂-1 。
Gut. 1994 Jul;35(7):969-75. doi: 10.1136/gut.35.7.969.
6
Cathepsin B and other proteases in human colorectal carcinoma.人结直肠癌中的组织蛋白酶B及其他蛋白酶
Am J Pathol. 1994 Aug;145(2):253-62.